These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20815854

  • 1. Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?
    McCormack L, Gadano A, Lendoire J, Imventarza O, Andriani O, Gil O, Toselli L, Bisigniano L, de Santibañes E.
    HPB (Oxford); 2010 Sep; 12(7):456-64. PubMed ID: 20815854
    [Abstract] [Full Text] [Related]

  • 2. Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant?
    McCormack L, Gadano A, Lendoire J, Quiñonez E, Imventarza O, Andriani O, Toselli L, Gil O, Gondolesi G, Bisigniano L, De Santibañes E.
    HPB (Oxford); 2010 Oct; 12(8):531-7. PubMed ID: 20887320
    [Abstract] [Full Text] [Related]

  • 3. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.
    Ann Hepatol; 2013 Oct; 12(3):440-7. PubMed ID: 23619261
    [Abstract] [Full Text] [Related]

  • 4. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L.
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [Abstract] [Full Text] [Related]

  • 5. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil.
    Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA.
    Transplant Proc; 2013 Jul; 45(6):2111-4. PubMed ID: 23747144
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Waiting list outcome of Peld/Meld exceptions: A single-center experience in Argentina.
    Lauferman L, Dip M, Halac E, Cervio G, Aredes D, Capparelli M, Reijenstein H, Minetto J, Rojas L, Goñi J, Jacobo Dillon A, Martinitto R, Imventarza O.
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29297966
    [Abstract] [Full Text] [Related]

  • 8. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D, French B, Abt P, Feng S, Cameron AM.
    Liver Transpl; 2012 Apr; 18(4):434-43. PubMed ID: 22271656
    [Abstract] [Full Text] [Related]

  • 9. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 10. Increasing the donor pool reduces the severity of liver disease: lessons learned from São Paulo, Brazil.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2286-8. PubMed ID: 23026575
    [Abstract] [Full Text] [Related]

  • 11. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, Hernandez-Alejandro R.
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [Abstract] [Full Text] [Related]

  • 12. Racial and ethnic disparities in access to liver transplantation.
    Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM.
    Liver Transpl; 2010 Sep; 16(9):1033-40. PubMed ID: 20818740
    [Abstract] [Full Text] [Related]

  • 13. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM.
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [Abstract] [Full Text] [Related]

  • 14. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.
    BMC Gastroenterol; 2009 Sep 25; 9():72. PubMed ID: 19778459
    [Abstract] [Full Text] [Related]

  • 15. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.
    Liver Transpl; 2011 Oct 25; 17(10):1137-51. PubMed ID: 21695771
    [Abstract] [Full Text] [Related]

  • 16. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar 25; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 17. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.
    Liver Transpl; 2012 Dec 25; 18(12):1456-63. PubMed ID: 22965903
    [Abstract] [Full Text] [Related]

  • 18. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM.
    Gastroenterology; 2011 Jun 25; 140(7):1952-60. PubMed ID: 21334338
    [Abstract] [Full Text] [Related]

  • 19. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb 25; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 20. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN.
    Transplantation; 2017 Jul 25; 101(7):1609-1615. PubMed ID: 28207639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.